Chemoinformaics analysis of 16-hydroxypalmitic acid
| Molecular Weight | 272.429 | nRot | 15 |
| Heavy Atom Molecular Weight | 240.173 | nRig | 1 |
| Exact Molecular Weight | 272.235 | nRing | 0 |
| Solubility: LogS | -3.507 | nHRing | 0 |
| Solubility: LogP | 5.007 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 50.4634 |
| nHD | 2 | BPOL | 32.9706 |
| QED | 0.431 |
| Synth | 1.748 |
| Natural Product Likeliness | 0.515 |
| NR-PPAR-gamma | 0.968 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.017 |
| Pgp-sub | 0 |
| HIA | 0.012 |
| CACO-2 | -5.25 |
| MDCK | 0.0000347 |
| BBB | 0.523 |
| PPB | 0.966578 |
| VDSS | 0.496 |
| FU | 0.014059 |
| CYP1A2-inh | 0.129 |
| CYP1A2-sub | 0.168 |
| CYP2c19-inh | 0.053 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.157 |
| CYP2c9-sub | 0.984 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.051 |
| CYP3a4-inh | 0.013 |
| CYP3a4-sub | 0.018 |
| CL | 2.877 |
| T12 | 0.757 |
| hERG | 0.043 |
| Ames | 0.005 |
| ROA | 0.019 |
| SkinSen | 0.913 |
| Carcinogencity | 0.093 |
| EI | 0.98 |
| Respiratory | 0.437 |
| NR-Aromatase | 0.139 |
| Antiviral | Yes |
| Prediction | 0.674789 |